Hrustanovic Gorjan

Director at Rain Enhancement Technologies Holdco, Inc. · on record since Apr 22, 2021
Director at Kymera Therapeutics, Inc. · on record since Aug 21, 2020
Director at Olema Pharmaceuticals, Inc. · on record since Nov 19, 2020

Insider trading activity of Hrustanovic Gorjan

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Price	Value · USD	Src
Kymera Therapeutics, Inc.	Jun 25, 2026	AwardD	6,068	0.00 USD	—	SEC
Olema Pharmaceuticals, Inc.	Jun 23, 2026	AwardD	29,500	0.00 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 26, 2025	AwardD	16,000	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 13, 2025	AwardD	24,150	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Jun 20, 2024	AwardD	16,000	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 18, 2024	AwardD	23,000	0.00 USD	$0	SEC
Rain Enhancement Technologies Holdco, Inc.	Jan 26, 2024	OtherD	-20,000	—	—	SEC
Rain Enhancement Technologies Holdco, Inc.	Jan 26, 2024	OtherD	-35,000	—	—	SEC
Rain Enhancement Technologies Holdco, Inc.	Aug 11, 2023	AwardD	35,000	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 21, 2023	AwardD	21,520	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Jun 20, 2023	AwardD	12,000	0.00 USD	$0	SEC
Rain Enhancement Technologies Holdco, Inc.	Aug 19, 2022	AwardD	20,000	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 27, 2022	AwardD	21,520	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 17, 2022	AwardD	21,520	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Jun 16, 2022	AwardD	12,000	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Jun 17, 2021	AwardD	20,063	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 10, 2021	AwardD	21,520	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Nov 19, 2020	AwardD	21,520	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Nov 19, 2020	AwardD	21,520	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Nov 19, 2020	AwardD	21,520	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Aug 21, 2020	AwardD	40,127	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Kymera Therapeutics, Inc.	Jun 25, 2026	AwardD	6,068	0.00 USD	—	SEC
Olema Pharmaceuticals, Inc.	Jun 23, 2026	AwardD	29,500	0.00 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 26, 2025	AwardD	16,000	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 13, 2025	AwardD	24,150	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Jun 20, 2024	AwardD	16,000	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 18, 2024	AwardD	23,000	0.00 USD	$0	SEC
Rain Enhancement Technologies Holdco, Inc.	Jan 26, 2024	OtherD	-20,000	—	—	SEC
Rain Enhancement Technologies Holdco, Inc.	Jan 26, 2024	OtherD	-35,000	—	—	SEC
Rain Enhancement Technologies Holdco, Inc.	Aug 11, 2023	AwardD	35,000	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 21, 2023	AwardD	21,520	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Jun 20, 2023	AwardD	12,000	0.00 USD	$0	SEC
Rain Enhancement Technologies Holdco, Inc.	Aug 19, 2022	AwardD	20,000	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 27, 2022	AwardD	21,520	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 17, 2022	AwardD	21,520	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Jun 16, 2022	AwardD	12,000	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Jun 17, 2021	AwardD	20,063	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Jun 10, 2021	AwardD	21,520	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Nov 19, 2020	AwardD	21,520	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Nov 19, 2020	AwardD	21,520	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Nov 19, 2020	AwardD	21,520	0.00 USD	$0	SEC
Kymera Therapeutics, Inc.	Aug 21, 2020	AwardD	40,127	0.00 USD	$0	SEC